CO2024006161A2 - Composiciones y métodos para el tratamiento de la lesión escamosa intraepitelial de alto grado (hsil) anal - Google Patents
Composiciones y métodos para el tratamiento de la lesión escamosa intraepitelial de alto grado (hsil) analInfo
- Publication number
- CO2024006161A2 CO2024006161A2 CONC2024/0006161A CO2024006161A CO2024006161A2 CO 2024006161 A2 CO2024006161 A2 CO 2024006161A2 CO 2024006161 A CO2024006161 A CO 2024006161A CO 2024006161 A2 CO2024006161 A2 CO 2024006161A2
- Authority
- CO
- Colombia
- Prior art keywords
- treatment
- methods
- squamous intraepithelial
- grade squamous
- intraepithelial lesion
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
- A61K2039/585—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation wherein the target is cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163270929P | 2021-10-22 | 2021-10-22 | |
| PCT/US2022/078551 WO2023070109A1 (en) | 2021-10-22 | 2022-10-21 | Compositions and methods for treating anal high-grade squamous intraepithelial lesion (hsil) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO2024006161A2 true CO2024006161A2 (es) | 2024-06-27 |
Family
ID=86059748
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CONC2024/0006161A CO2024006161A2 (es) | 2021-10-22 | 2024-05-15 | Composiciones y métodos para el tratamiento de la lesión escamosa intraepitelial de alto grado (hsil) anal |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230233659A1 (enExample) |
| EP (1) | EP4419138A4 (enExample) |
| JP (1) | JP2024539188A (enExample) |
| KR (1) | KR20240099266A (enExample) |
| CN (1) | CN118382457A (enExample) |
| AU (1) | AU2022371672A1 (enExample) |
| CA (1) | CA3235779A1 (enExample) |
| CO (1) | CO2024006161A2 (enExample) |
| MX (1) | MX2024004878A (enExample) |
| WO (1) | WO2023070109A1 (enExample) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3421046A1 (en) * | 2014-11-04 | 2019-01-02 | Janssen Vaccines & Prevention B.V. | Therapeutic hpv16 vaccines |
| HK1252967A1 (zh) * | 2015-08-20 | 2019-06-06 | Janssen Vaccines & Prevention B.V. | 治疗性hpv18疫苗 |
| KR20250008956A (ko) * | 2017-05-11 | 2025-01-16 | 이노비오 파마수티컬즈, 인크. | 면역요법 후 고등급 자궁경부 이형성증의 회귀 및 hpv16 및 hpv18 감염의 클리어런스를 위한 임상적 및 면역학적 바이오마커 |
| US20230277645A1 (en) * | 2020-04-02 | 2023-09-07 | Inovio Pharmaceuticals, Inc. | Compositions and methods for treating vulvar dysplasia |
-
2022
- 2022-10-21 CA CA3235779A patent/CA3235779A1/en active Pending
- 2022-10-21 JP JP2024523770A patent/JP2024539188A/ja active Pending
- 2022-10-21 MX MX2024004878A patent/MX2024004878A/es unknown
- 2022-10-21 CN CN202280082724.8A patent/CN118382457A/zh active Pending
- 2022-10-21 EP EP22884739.8A patent/EP4419138A4/en active Pending
- 2022-10-21 KR KR1020247015465A patent/KR20240099266A/ko active Pending
- 2022-10-21 US US18/048,776 patent/US20230233659A1/en active Pending
- 2022-10-21 AU AU2022371672A patent/AU2022371672A1/en active Pending
- 2022-10-21 WO PCT/US2022/078551 patent/WO2023070109A1/en not_active Ceased
-
2024
- 2024-05-15 CO CONC2024/0006161A patent/CO2024006161A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20240099266A (ko) | 2024-06-28 |
| MX2024004878A (es) | 2024-07-15 |
| JP2024539188A (ja) | 2024-10-28 |
| WO2023070109A1 (en) | 2023-04-27 |
| US20230233659A1 (en) | 2023-07-27 |
| CN118382457A (zh) | 2024-07-23 |
| EP4419138A1 (en) | 2024-08-28 |
| CA3235779A1 (en) | 2023-04-27 |
| EP4419138A4 (en) | 2026-03-04 |
| AU2022371672A1 (en) | 2024-05-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2022017989A2 (es) | Vacunas para la papilomatosis respiratoria recurrente y métodos para usar estas | |
| UY39060A (es) | Composiciones y métodos para prevenir y tratar la infección por coronavirus - vacunas sars-cov-2 | |
| MX2019000252A (es) | Administracion viral oncolitica pseudotipada de polipeptidos terapeuticos. | |
| WO2017191258A8 (en) | INFLUENZA MRNA VACCINES | |
| MX2022003658A (es) | Vacunas contra el virus de la hepatitis b (vhb) y metodos para tratar el vhb. | |
| CY1121377T1 (el) | Θεραπευτικα εμβολια hpv16 | |
| MX2020009262A (es) | Vectores de parapoxvirus. | |
| MX2022010588A (es) | Vacuna basada en poxvirus recombinantes contra el virus sars-cov-2. | |
| MX2019003158A (es) | Vectores de adenovirus canino. | |
| WO2009092038A8 (en) | Influenza dna vaccination and methods of use thereof | |
| EA201591688A1 (ru) | Усовершенствованные вакцины против вируса папилломы человека и способы их применения | |
| EA201892200A1 (ru) | Замещенные производные соединений индола в качестве ингибиторов репликации вирусов денге | |
| MX2011007692A (es) | Vacunas mejoradas para el virus del papiloma humano y procedimientos para su utilizacion. | |
| EA202091769A1 (ru) | Вакцины против вируса гриппа и пути их применения | |
| BR112018072372A2 (pt) | combinações de vacina terapêutica contra o hpv | |
| MX2023007229A (es) | Constructo de arn. | |
| EA202191147A1 (ru) | Вакцина виб h52 с гетерологичным шиповидным белком | |
| Ellerhoff et al. | Novel epi-virotherapeutic treatment of pancreatic cancer combining the oral histone deacetylase inhibitor resminostat with oncolytic measles vaccine virus | |
| CL2012000783A1 (es) | Proceso para mejorar la eficacia de proteccion metodo para inducir una respuesta inmune contra el virus del dengue que comprende vacunas de dna y virus quimericos 17d; composicion vacunal que comprende vacunas de dna contra los cuatro serotipos del virus dengue y virus quimericos comprendiendo el virus vacunal de fiebre amarilla; plasmido recombinante conteniendo el gen de la proteína e. | |
| AR108014A1 (es) | Vacuna universal para enfermedades virales y método de vacunación | |
| MX2022004836A (es) | Vacunas mejoradas para la papilomatosis respiratoria recurrente y métodos para su uso. | |
| WO2021202949A3 (en) | Compositions and methods for treating vulvar dysplasia | |
| PH12021553186A1 (en) | Chikungunya vaccine formulations | |
| MX2014004537A (es) | Vacunas para el virus del papiloma humano y metodos para su uso. | |
| CL2009000791A1 (es) | Compuestos derivados de labirintopeptina; procedimiento para prepararlos que comprende fermentar la cepa actinomadura namibiensis (dsm 6313); uso de los compuestos para tratar infecciones bacterianas, infecciones viricas y/o dolor; composicion farmaceutica que los comprenden; dna que codifica la preprolabirintopeptina a2. |